Welcome from the Division Chiefs
Welcome to the website for the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University. We are incredibly proud of our tradition and accomplishments in contributing to the advancement of treatment of infectious diseases locally, nationally and worldwide.
Our core mission is to heal, to teach and to discover. Facing the challenges of emerging and re-emerging infectious diseases at home and across the globe; we pride ourselves on delivering the highest quality of care for our patients, providing exceptional fellowship training to the next generation of Infectious Diseases physicians and continuing to make scientific breakthroughs through our world renowned research.
STERIS Corporation Support
Announcement of Infectious Diseases Research Support from STERIS Corporation
The Division of Infectious Diseases & HIV Medicine at Case Western Reserve University and University Hospitals Cleveland Medical Center, with funds from STERIS Corporation, will provide seed money to faculty to foster research in emerging and healthcare-associated infections. Please follow the link to the RFA here. For more information contact Martha Salata at 844-1988 or firstname.lastname@example.org.
2016 STERIS Corporation RFA (Word Document)
CWRU receives grant to study why some HIV positive people resist TB
Crain's Business Cleveland
Case Western Reserve University School of Medicine experts and colleagues in the United States and Africa have received an $11 million federal grant to study how some people living with the human immunodeficiency virus (HIV) in Africa avoid contracting tuberculosis.
The five-year grant will support work to learn what causes resistance to the bacterium that causes TB. Understanding this could have a significant global health impact, as TB is the leading cause of death worldwide among people living with HIV, with one in three HIV deaths estimated to be due to TB, according to a news release.
Faculty Distinguished Research Award Winner
In his 36 years as a faculty member, Dr. Lederman has made an incredible impact on Case Western Reserve University School of Medicine. But his contributions extend well beyond campus.
Two years after the discovery of HIV/AIDS in 1981, Lederman began researching the disease, focusing mainly on understanding and addressing HIV-induced immune deficiency. Then, two years into his work, he established the first dedicated HIV clinic in Northeast Ohio.
Lederman is responsible for the AIDS Clinical Trials Unit at Case Western Reserve and directs the network of Immunology Service Laboratories, which monitors national HIV treatment trials. His leadership extends into his involvement in the Association of American Physicians, the American Association of Immunologists, the Infectious Diseases Society of America, the HIV Medicine Association, the American Association of Microbiology and the American Association for the Advancement of Science. Read more...
SHEA Member Spotlight
The Society for Healthcare Epidemiology of America (SHEA) has written a member spotlight on Dr. Robin Jump.
Dr. Robin Jump is a physician-scientist with the Geriatric Research, Education and Clinical Center (GRECC) and the Louis Stokes Cleveland Veterans Affairs Medical Center. She is also an Assistant Professor of Medicine in the Division of Infectious Diseases and HIV Medicine at Case Western Reserve University.
In 2009, Dr. Jump established an infectious disease consultation service for the Cleveland VA’s long-term care facility, reducing overall antimicrobial use by 30% over 18 months. Read more...
Dr. Stiefel Honored by Women Faculty of School of Medicine
Congratulations to Dr. Usha Stiefel for winning the 2016 Helen Evans Mid-Career Faculty Development Award from the Women Faculty of the School of Medicine at Case. This award is given for outstanding potential for a promising career in Academic Medicine.
Dr. Stiefel will be honored at the AAMC this year. Dr. Stiefel will also receive recognition at the WFSOM spring dinner meeting on Monday, April 4, 2016 when this award will be announced.